Clinical Scorecard: Case Study: Uncommon Collision Tumors Involving an ACTH-Producing Pituitary Neuroendocrine Tumor and Pituicytoma – A Histopathological and Ultrastructural Examination
At a Glance
Category
Detail
Condition
Collision tumors composed of ACTH-secreting pituitary neuroendocrine tumor (PitNET) and pituicytoma
Key Mechanisms
Coexistence of two histologically distinct neoplasms in the sellar region without tissue admixture; ACTH secretion causing Cushing’s disease
Target Population
Patients with pituitary region tumors, specifically those presenting with Cushing’s disease symptoms
Care Setting
Endocrinology and neurosurgical care centers with access to advanced imaging and histopathological analysis
Key Highlights
Collision tumors involving PitNET and pituicytoma are exceptionally rare and challenging to diagnose preoperatively.
Pituicytomas are benign WHO Grade I tumors originating from neurohypophyseal glial cells, rarely associated with pituitary hyperfunction.
Definitive diagnosis requires histopathological, immunohistochemical, and ultrastructural examination following surgical resection.
Guideline-Based Recommendations
Diagnosis
Consider collision tumors in patients with atypical pituitary lesions and clinical signs of hormone hypersecretion.
Use MRI to identify sellar lesions, noting features such as nodular hypointense lesions on T2-weighted images.
Confirm diagnosis via histopathological and immunohistochemical analysis including ACTH staining, Ki-67 proliferation index, and TTF-1 nuclear positivity.
Ultrastructural examination can aid in distinguishing morphologically distinct tumor components.
Management
Perform transnasal transsphenoidal surgical resection for tumor removal.
Initiate hormone replacement therapy as needed for pituitary axis deficiencies (e.g., levothyroxine for central hypothyroidism).
Monitor and manage postoperative complications such as diabetes insipidus.
Monitoring & Follow-up
Conduct regular clinical and biochemical follow-up to assess remission status and detect tumor recurrence.
Use imaging studies postoperatively to confirm absence of residual tumor.
Risks
Potential postoperative development of diabetes insipidus.
Diagnostic delays may contribute to severe comorbidities and increased mortality in Cushing’s disease.
Difficulty in preoperative identification of collision tumors may affect treatment planning.
Patient & Prescribing Data
Young adult female with clinical and biochemical features of Cushing’s disease and central hypothyroidism
Surgical resection combined with hormone replacement therapy can achieve clinical and biochemical remission; close monitoring for complications is essential.
Clinical Best Practices
Maintain high suspicion for collision tumors in atypical pituitary presentations to guide appropriate diagnostic workup.
Employ comprehensive histopathological and immunohistochemical evaluation to differentiate tumor components.
Provide multidisciplinary care involving endocrinology, neurosurgery, and pathology for optimal management.
Report rare cases to enhance understanding and improve diagnostic and therapeutic strategies.
by Silvia Carolina Fernández, María Celina Bernhardt, Ezequiel Grondona, Carolina Leimgruber, Virginia Juárez, Ana Clara Venier, María Lorena Bertolino, Emilio Mezzano, Jorge Humberto Mukdsi, Favio Nicolás Pesaola, Ana Lucía De Paul
